Biography
Georgia Kalogianni is a PhD candidate in Biomedical Engineering at the University of Technology Sydney (UTS) and a member of the Cardiovascular Regeneration Group at the Heart Research Institute (HRI), under the supervision of Associate Professor Carmine Gentile.
Her research focuses on the development of advanced in vitro cardiac models that integrate 3D bioprinting, microfluidics, and vascularised cardiac spheroids to improve the physiological relevance of drug testing platforms. Specifically, her work lies at the interface of cardio-oncology, where she investigates chemotherapy-induced cardiotoxicity and therapeutic efficacy using multi-tissue and multi-compartment organ-on-a-chip systems.
Her research addresses key limitations in current preclinical cardiac models by improving their translational relevance for drug testing. Through this work, she aims to support more accurate assessment of cardiac safety and therapeutic responses in clinically relevant settings.
Selected Publication
D. Idais, C. D. Roche, G. Kalogianni, L. Polonchuk, and C. Gentile, "Generation and applications of cardiac spheroids," npj Biomedical Innovations, vol. 2, no. 1, p. 17, 2025/06/10 2025, doi: 10.1038/s44385-025-00024-y.
